Publications Office of the EU
Προσφορά για την προμήθεια Αντινεοπλασματικών Φαρμάκων Φ.Υ.Υ 15/2025 (ΟΑΥ) - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Προσφορά για την προμήθεια Αντινεοπλασματικών Φαρμάκων Φ.Υ.Υ 15/2025 (ΟΑΥ)

Overview
  • Published
    17/02/2025
  • Deadline
    20/03/2025
  • Opening of tenders
    20/03/2025
  • Awarded
    14/05/2025
  • Today
    17/03/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Υπουργείο Υγείας
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CY000 Κύπρος
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
710,552.00 EUR
Total final contract value (excluding VAT)
Not available
Number of lots
8
Procedure details
Tender reference number
13.25.02.08.216
Description

Προμήθεια Αντινεοπλασματικών Φαρμάκων

Submission Method
Electronic via:
https://www.eprocurement.gov.cy/epps/cft/prepareViewCfTWS.do?resourceId=7347054
Tenders may be submitted
Electronic submission: required
https://www.eprocurement.gov.cy/epps/cft/prepareViewCfTWS.do?resourceId=7347054
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
20/03/2025 12:30
Place of performance
CY000 Κύπρος
CY Κύπρος (Kýpros)
CPV code

33652100 - Antineoplastic agents

Lots (8)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.